Transforming growth factor (TGF)-β1, a potent immunoregulatory molecule, was found to control the life and death decisions of T lymphocytes. Both thymic and peripheral T cell apoptosis was increased in mice lacking TGF-β1 (TGF-β1−/−) compared with wild-type littermates. Engagement of the T cell receptor enhanced this aberrant T cell apoptosis, as did signaling through either the death receptor Fas or the tumor necrosis factor α receptor in peripheral T cells. Strikingly, TGF-β was localized within the mitochondria of normal T cells, and the absence of TGF-β1 resulted in disruption of mitochondrial membrane potential (Δψm), which marks the point of no return in a cell condemned to die. This TGF-β–dependent regulation of viability appears dissociable from the TGF-β1 membrane receptor–Smad3 signaling pathway, but associated with a mitochondrial antiapoptotic protein Bcl–XL. Thus, TGF-β1 may protect T cells at multiple sites in the death pathway, particularly by maintaining the essential integrity of mitochondria. These findings may have broad implications not only for T cell selection and death in immune responses and in the generation of tolerance, but also for defining the mechanisms of programmed cell death in general.
Skip Nav Destination
Article navigation
20 August 2001
Article|
August 20 2001
Requirement for Transforming Growth Factor β1 in Controlling T Cell Apoptosis
WanJun Chen,
WanJun Chen
aCellular Immunology Section, Oral Infection and Immunity Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland 20892
Search for other works by this author on:
Wenwen Jin,
Wenwen Jin
aCellular Immunology Section, Oral Infection and Immunity Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland 20892
Search for other works by this author on:
Hongsheng Tian,
Hongsheng Tian
aCellular Immunology Section, Oral Infection and Immunity Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland 20892
Search for other works by this author on:
Paula Sicurello,
Paula Sicurello
bDepartment of Pathology, George Washington University, Washington, DC 20037
Search for other works by this author on:
Mark Frank,
Mark Frank
aCellular Immunology Section, Oral Infection and Immunity Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland 20892
Search for other works by this author on:
Jan M. Orenstein,
Jan M. Orenstein
bDepartment of Pathology, George Washington University, Washington, DC 20037
Search for other works by this author on:
Sharon M. Wahl
Sharon M. Wahl
aCellular Immunology Section, Oral Infection and Immunity Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland 20892
Search for other works by this author on:
WanJun Chen
aCellular Immunology Section, Oral Infection and Immunity Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland 20892
Wenwen Jin
aCellular Immunology Section, Oral Infection and Immunity Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland 20892
Hongsheng Tian
aCellular Immunology Section, Oral Infection and Immunity Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland 20892
Paula Sicurello
bDepartment of Pathology, George Washington University, Washington, DC 20037
Mark Frank
aCellular Immunology Section, Oral Infection and Immunity Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland 20892
Jan M. Orenstein
bDepartment of Pathology, George Washington University, Washington, DC 20037
Sharon M. Wahl
aCellular Immunology Section, Oral Infection and Immunity Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland 20892
Abbreviations used in this paper: 7-AAD, 7-amino-actinomycin D; Δψm, mitochondrial membrane potential; AICD, activation-induced cell death; DiOC6, 3,3′-dihexyloxacarbocyanine iodide; DP, double positive; ER, endoplasmic reticulum; FasL, Fas ligand; GAPDH, glyceraldehyde 3-phosphate dehydrogenase gene; PALS, periarteriolar lymphatic sheath; TUNEL, terminal deoxynucleotidyl transferase (TdT)-mediated dUTP-biotin nick end-labeling.
Received:
May 12 2000
Revision Requested:
May 25 2001
Accepted:
June 12 2001
Online ISSN: 1540-9538
Print ISSN: 0022-1007
© 2001 The Rockefeller University Press
2001
The Rockefeller University Press
J Exp Med (2001) 194 (4): 439–454.
Article history
Received:
May 12 2000
Revision Requested:
May 25 2001
Accepted:
June 12 2001
Citation
WanJun Chen, Wenwen Jin, Hongsheng Tian, Paula Sicurello, Mark Frank, Jan M. Orenstein, Sharon M. Wahl; Requirement for Transforming Growth Factor β1 in Controlling T Cell Apoptosis. J Exp Med 20 August 2001; 194 (4): 439–454. doi: https://doi.org/10.1084/jem.194.4.439
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement